nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.0283	0.0394	CbGbCtD
Perphenazine—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.0266	0.037	CbGbCtD
Perphenazine—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.0266	0.037	CbGbCtD
Perphenazine—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.0241	0.0335	CbGbCtD
Perphenazine—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.0202	0.028	CbGbCtD
Perphenazine—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.0183	0.0254	CbGbCtD
Perphenazine—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0182	0.0253	CbGbCtD
Perphenazine—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0182	0.0253	CbGbCtD
Perphenazine—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.018	0.025	CbGbCtD
Perphenazine—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0169	0.0235	CbGbCtD
Perphenazine—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0166	0.0231	CbGbCtD
Perphenazine—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0156	0.0217	CbGbCtD
Perphenazine—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0156	0.0217	CbGbCtD
Perphenazine—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0153	0.0213	CbGbCtD
Perphenazine—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0153	0.0213	CbGbCtD
Perphenazine—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.015	0.0208	CbGbCtD
Perphenazine—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0141	0.0196	CbGbCtD
Perphenazine—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0141	0.0195	CbGbCtD
Perphenazine—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0141	0.0195	CbGbCtD
Perphenazine—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0138	0.0192	CbGbCtD
Perphenazine—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0138	0.0192	CbGbCtD
Perphenazine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0137	0.019	CbGbCtD
Perphenazine—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0133	0.0184	CbGbCtD
Perphenazine—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0132	0.0184	CbGbCtD
Perphenazine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0129	0.0179	CbGbCtD
Perphenazine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0129	0.0179	CbGbCtD
Perphenazine—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0128	0.0178	CbGbCtD
Perphenazine—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0127	0.0177	CbGbCtD
Perphenazine—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0127	0.0177	CbGbCtD
Perphenazine—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0118	0.0164	CbGbCtD
Perphenazine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0116	0.0162	CbGbCtD
Perphenazine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0116	0.0162	CbGbCtD
Perphenazine—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0116	0.0161	CbGbCtD
Perphenazine—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0116	0.0161	CbGbCtD
Perphenazine—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0111	0.0155	CbGbCtD
Perphenazine—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.011	0.0153	CbGbCtD
Perphenazine—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0107	0.0149	CbGbCtD
Perphenazine—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0107	0.0148	CbGbCtD
Perphenazine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.01	0.014	CbGbCtD
Perphenazine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00975	0.0135	CbGbCtD
Perphenazine—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00965	0.0134	CbGbCtD
Perphenazine—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00965	0.0134	CbGbCtD
Perphenazine—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00925	0.0128	CbGbCtD
Perphenazine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00882	0.0123	CbGbCtD
Perphenazine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00882	0.0123	CbGbCtD
Perphenazine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0087	0.0121	CbGbCtD
Perphenazine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00818	0.0114	CbGbCtD
Perphenazine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00818	0.0114	CbGbCtD
Perphenazine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0074	0.0103	CbGbCtD
Perphenazine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0074	0.0103	CbGbCtD
Perphenazine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00639	0.00887	CbGbCtD
Perphenazine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0062	0.00861	CbGbCtD
Perphenazine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00561	0.00779	CbGbCtD
Perphenazine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00561	0.00779	CbGbCtD
Perphenazine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00538	0.00747	CbGbCtD
Perphenazine—CALM2—semen—acquired immunodeficiency syndrome	0.00302	0.0417	CbGeAlD
Perphenazine—CALM1—semen—acquired immunodeficiency syndrome	0.00301	0.0415	CbGeAlD
Perphenazine—DRD1—nerve—acquired immunodeficiency syndrome	0.00227	0.0313	CbGeAlD
Perphenazine—CALM2—nerve—acquired immunodeficiency syndrome	0.00146	0.0201	CbGeAlD
Perphenazine—CALM1—nerve—acquired immunodeficiency syndrome	0.00145	0.02	CbGeAlD
Perphenazine—HTR7—nerve—acquired immunodeficiency syndrome	0.00142	0.0196	CbGeAlD
Perphenazine—DRD2—nerve—acquired immunodeficiency syndrome	0.00134	0.0185	CbGeAlD
Perphenazine—CALM2—endothelium—acquired immunodeficiency syndrome	0.00124	0.0171	CbGeAlD
Perphenazine—CALM1—endothelium—acquired immunodeficiency syndrome	0.00123	0.017	CbGeAlD
Perphenazine—HTR7—endothelium—acquired immunodeficiency syndrome	0.00121	0.0166	CbGeAlD
Perphenazine—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.00112	0.0155	CbGeAlD
Perphenazine—CALM2—blood plasma—acquired immunodeficiency syndrome	0.0011	0.0152	CbGeAlD
Perphenazine—CALM1—blood plasma—acquired immunodeficiency syndrome	0.0011	0.0151	CbGeAlD
Perphenazine—HTR7—blood plasma—acquired immunodeficiency syndrome	0.00107	0.0148	CbGeAlD
Perphenazine—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00105	0.0144	CbGeAlD
Perphenazine—CYP2C18—digestive system—acquired immunodeficiency syndrome	0.000946	0.0131	CbGeAlD
Perphenazine—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000913	0.0126	CbGeAlD
Perphenazine—HTR2A—nerve—acquired immunodeficiency syndrome	0.000883	0.0122	CbGeAlD
Perphenazine—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000854	0.0118	CbGeAlD
Perphenazine—CYP2C18—vagina—acquired immunodeficiency syndrome	0.000835	0.0115	CbGeAlD
Perphenazine—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.000819	0.0113	CbGeAlD
Perphenazine—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000811	0.0112	CbGeAlD
Perphenazine—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.000785	0.0108	CbGeAlD
Perphenazine—CALM3—retina—acquired immunodeficiency syndrome	0.000768	0.0106	CbGeAlD
Perphenazine—HTR2A—endothelium—acquired immunodeficiency syndrome	0.000752	0.0104	CbGeAlD
Perphenazine—HTR6—nervous system—acquired immunodeficiency syndrome	0.000685	0.00946	CbGeAlD
Perphenazine—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.000668	0.00922	CbGeAlD
Perphenazine—HTR6—central nervous system—acquired immunodeficiency syndrome	0.00066	0.00911	CbGeAlD
Perphenazine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000618	0.00854	CbGeAlD
Perphenazine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000608	0.0084	CbGeAlD
Perphenazine—CALM2—retina—acquired immunodeficiency syndrome	0.000603	0.00833	CbGeAlD
Perphenazine—CALM1—retina—acquired immunodeficiency syndrome	0.0006	0.00829	CbGeAlD
Perphenazine—AOX1—digestive system—acquired immunodeficiency syndrome	0.000599	0.00827	CbGeAlD
Perphenazine—DRD2—retina—acquired immunodeficiency syndrome	0.000554	0.00766	CbGeAlD
Perphenazine—CALM2—skin of body—acquired immunodeficiency syndrome	0.000529	0.00731	CbGeAlD
Perphenazine—AOX1—vagina—acquired immunodeficiency syndrome	0.000529	0.0073	CbGeAlD
Perphenazine—CALM1—skin of body—acquired immunodeficiency syndrome	0.000527	0.00728	CbGeAlD
Perphenazine—HTR6—brain—acquired immunodeficiency syndrome	0.000524	0.00723	CbGeAlD
Perphenazine—CALM3—blood—acquired immunodeficiency syndrome	0.000514	0.00709	CbGeAlD
Perphenazine—DRD1—nervous system—acquired immunodeficiency syndrome	0.00051	0.00704	CbGeAlD
Perphenazine—AOX1—lung—acquired immunodeficiency syndrome	0.0005	0.0069	CbGeAlD
Perphenazine—CALM3—bone marrow—acquired immunodeficiency syndrome	0.000497	0.00686	CbGeAlD
Perphenazine—CALM3—spinal cord—acquired immunodeficiency syndrome	0.000495	0.00683	CbGeAlD
Perphenazine—DRD1—central nervous system—acquired immunodeficiency syndrome	0.000491	0.00677	CbGeAlD
Perphenazine—CALM3—vagina—acquired immunodeficiency syndrome	0.000476	0.00658	CbGeAlD
Perphenazine—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.00047	0.00649	CbGeAlD
Perphenazine—CALM3—lung—acquired immunodeficiency syndrome	0.00045	0.00622	CbGeAlD
Perphenazine—CALM2—lymphoid tissue—acquired immunodeficiency syndrome	0.000429	0.00592	CbGeAlD
Perphenazine—CALM1—lymphoid tissue—acquired immunodeficiency syndrome	0.000427	0.00589	CbGeAlD
Perphenazine—CALM2—digestive system—acquired immunodeficiency syndrome	0.000424	0.00585	CbGeAlD
Perphenazine—CALM1—digestive system—acquired immunodeficiency syndrome	0.000422	0.00582	CbGeAlD
Perphenazine—HTR7—digestive system—acquired immunodeficiency syndrome	0.000412	0.00569	CbGeAlD
Perphenazine—CALM2—blood—acquired immunodeficiency syndrome	0.000403	0.00557	CbGeAlD
Perphenazine—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000402	0.00555	CbGeAlD
Perphenazine—CALM1—blood—acquired immunodeficiency syndrome	0.000402	0.00554	CbGeAlD
Perphenazine—HTR2C—nervous system—acquired immunodeficiency syndrome	0.000396	0.00547	CbGeAlD
Perphenazine—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000396	0.00546	CbGeAlD
Perphenazine—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000394	0.00543	CbGeAlD
Perphenazine—HTR7—blood—acquired immunodeficiency syndrome	0.000392	0.00542	CbGeAlD
Perphenazine—CALM2—bone marrow—acquired immunodeficiency syndrome	0.00039	0.00539	CbGeAlD
Perphenazine—DRD1—brain—acquired immunodeficiency syndrome	0.00039	0.00538	CbGeAlD
Perphenazine—CALM2—spinal cord—acquired immunodeficiency syndrome	0.000389	0.00537	CbGeAlD
Perphenazine—CALM1—bone marrow—acquired immunodeficiency syndrome	0.000389	0.00537	CbGeAlD
Perphenazine—CALM1—spinal cord—acquired immunodeficiency syndrome	0.000387	0.00534	CbGeAlD
Perphenazine—CYP2C19—blood—acquired immunodeficiency syndrome	0.000383	0.00529	CbGeAlD
Perphenazine—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.000381	0.00526	CbGeAlD
Perphenazine—HTR7—spinal cord—acquired immunodeficiency syndrome	0.000378	0.00522	CbGeAlD
Perphenazine—CALM2—vagina—acquired immunodeficiency syndrome	0.000374	0.00516	CbGeAlD
Perphenazine—CALM1—vagina—acquired immunodeficiency syndrome	0.000372	0.00514	CbGeAlD
Perphenazine—HTR2A—retina—acquired immunodeficiency syndrome	0.000366	0.00505	CbGeAlD
Perphenazine—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000355	0.0049	CbGeAlD
Perphenazine—AOX1—brain—acquired immunodeficiency syndrome	0.000354	0.00489	CbGeAlD
Perphenazine—CALM2—lung—acquired immunodeficiency syndrome	0.000354	0.00488	CbGeAlD
Perphenazine—CALM1—lung—acquired immunodeficiency syndrome	0.000352	0.00486	CbGeAlD
Perphenazine—HTR7—lung—acquired immunodeficiency syndrome	0.000344	0.00475	CbGeAlD
Perphenazine—AOX1—lymph node—acquired immunodeficiency syndrome	0.000342	0.00472	CbGeAlD
Perphenazine—CYP2C8—blood—acquired immunodeficiency syndrome	0.000334	0.00462	CbGeAlD
Perphenazine—HTR1A—nervous system—acquired immunodeficiency syndrome	0.000333	0.0046	CbGeAlD
Perphenazine—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000328	0.00453	CbGeAlD
Perphenazine—CALM2—nervous system—acquired immunodeficiency syndrome	0.000328	0.00452	CbGeAlD
Perphenazine—CALM1—nervous system—acquired immunodeficiency syndrome	0.000326	0.0045	CbGeAlD
Perphenazine—DRD2—lung—acquired immunodeficiency syndrome	0.000325	0.00449	CbGeAlD
Perphenazine—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.000321	0.00443	CbGeAlD
Perphenazine—CALM3—brain—acquired immunodeficiency syndrome	0.000319	0.0044	CbGeAlD
Perphenazine—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000319	0.0044	CbGeAlD
Perphenazine—HTR7—nervous system—acquired immunodeficiency syndrome	0.000318	0.0044	CbGeAlD
Perphenazine—CALM2—central nervous system—acquired immunodeficiency syndrome	0.000315	0.00435	CbGeAlD
Perphenazine—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.000315	0.00435	CbGeAlD
Perphenazine—CALM1—central nervous system—acquired immunodeficiency syndrome	0.000314	0.00433	CbGeAlD
Perphenazine—CYP1A2—blood—acquired immunodeficiency syndrome	0.000313	0.00432	CbGeAlD
Perphenazine—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000312	0.0043	CbGeAlD
Perphenazine—CYP2C8—vagina—acquired immunodeficiency syndrome	0.00031	0.00428	CbGeAlD
Perphenazine—CALM3—lymph node—acquired immunodeficiency syndrome	0.000308	0.00425	CbGeAlD
Perphenazine—HRH1—digestive system—acquired immunodeficiency syndrome	0.000307	0.00425	CbGeAlD
Perphenazine—HTR7—central nervous system—acquired immunodeficiency syndrome	0.000307	0.00423	CbGeAlD
Perphenazine—HTR2C—brain—acquired immunodeficiency syndrome	0.000303	0.00418	CbGeAlD
Perphenazine—DRD2—nervous system—acquired immunodeficiency syndrome	0.000301	0.00416	CbGeAlD
Perphenazine—CYP2B6—blood—acquired immunodeficiency syndrome	0.0003	0.00414	CbGeAlD
Perphenazine—CYP2C9—blood—acquired immunodeficiency syndrome	0.000297	0.0041	CbGeAlD
Perphenazine—Infection—Abacavir—acquired immunodeficiency syndrome	0.000291	0.00174	CcSEcCtD
Perphenazine—DRD2—central nervous system—acquired immunodeficiency syndrome	0.00029	0.004	CbGeAlD
Perphenazine—Angioedema—Zidovudine—acquired immunodeficiency syndrome	0.000289	0.00173	CcSEcCtD
Perphenazine—ADRA2A—blood—acquired immunodeficiency syndrome	0.000288	0.00397	CbGeAlD
Perphenazine—Anorexia—Nelfinavir—acquired immunodeficiency syndrome	0.000284	0.0017	CcSEcCtD
Perphenazine—Syncope—Zidovudine—acquired immunodeficiency syndrome	0.000284	0.00169	CcSEcCtD
Perphenazine—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.000283	0.00169	CcSEcCtD
Perphenazine—Anorexia—Stavudine—acquired immunodeficiency syndrome	0.000283	0.00169	CcSEcCtD
Perphenazine—Muscle spasms—Indinavir—acquired immunodeficiency syndrome	0.000283	0.00169	CcSEcCtD
Perphenazine—Jaundice—Lamivudine—acquired immunodeficiency syndrome	0.000282	0.00168	CcSEcCtD
Perphenazine—Hypoaesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000281	0.00168	CcSEcCtD
Perphenazine—Anorexia—Abacavir—acquired immunodeficiency syndrome	0.000279	0.00167	CcSEcCtD
Perphenazine—Oedema peripheral—Ritonavir—acquired immunodeficiency syndrome	0.000278	0.00166	CcSEcCtD
Perphenazine—Loss of consciousness—Zidovudine—acquired immunodeficiency syndrome	0.000278	0.00166	CcSEcCtD
Perphenazine—CYP2B6—vagina—acquired immunodeficiency syndrome	0.000278	0.00384	CbGeAlD
Perphenazine—Erythema—Efavirenz—acquired immunodeficiency syndrome	0.000278	0.00166	CcSEcCtD
Perphenazine—Vision blurred—Indinavir—acquired immunodeficiency syndrome	0.000277	0.00166	CcSEcCtD
Perphenazine—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.000277	0.00383	CbGeAlD
Perphenazine—Cough—Zidovudine—acquired immunodeficiency syndrome	0.000276	0.00165	CcSEcCtD
Perphenazine—CYP1A2—lung—acquired immunodeficiency syndrome	0.000274	0.00379	CbGeAlD
Perphenazine—Convulsion—Zidovudine—acquired immunodeficiency syndrome	0.000274	0.00164	CcSEcCtD
Perphenazine—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.000273	0.00163	CcSEcCtD
Perphenazine—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.000273	0.00163	CcSEcCtD
Perphenazine—HRH1—vagina—acquired immunodeficiency syndrome	0.000272	0.00375	CbGeAlD
Perphenazine—Hypoaesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000271	0.00162	CcSEcCtD
Perphenazine—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.00027	0.00161	CcSEcCtD
Perphenazine—Agitation—Indinavir—acquired immunodeficiency syndrome	0.00027	0.00161	CcSEcCtD
Perphenazine—Agranulocytosis—Lamivudine—acquired immunodeficiency syndrome	0.00027	0.00161	CcSEcCtD
Perphenazine—Insomnia—Nelfinavir—acquired immunodeficiency syndrome	0.000269	0.00161	CcSEcCtD
Perphenazine—Angioedema—Indinavir—acquired immunodeficiency syndrome	0.000269	0.0016	CcSEcCtD
Perphenazine—Insomnia—Stavudine—acquired immunodeficiency syndrome	0.000269	0.0016	CcSEcCtD
Perphenazine—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.000267	0.0016	CcSEcCtD
Perphenazine—ADRA2A—vagina—acquired immunodeficiency syndrome	0.000267	0.00368	CbGeAlD
Perphenazine—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.000266	0.00159	CcSEcCtD
Perphenazine—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.000266	0.00159	CcSEcCtD
Perphenazine—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000266	0.00159	CcSEcCtD
Perphenazine—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.000265	0.00158	CcSEcCtD
Perphenazine—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.000265	0.00158	CcSEcCtD
Perphenazine—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.000264	0.00158	CcSEcCtD
Perphenazine—Syncope—Indinavir—acquired immunodeficiency syndrome	0.000264	0.00158	CcSEcCtD
Perphenazine—Pain—Nevirapine—acquired immunodeficiency syndrome	0.000263	0.00157	CcSEcCtD
Perphenazine—CYP2B6—lung—acquired immunodeficiency syndrome	0.000263	0.00363	CbGeAlD
Perphenazine—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.000262	0.00156	CcSEcCtD
Perphenazine—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.000261	0.00156	CcSEcCtD
Perphenazine—Confusional state—Zidovudine—acquired immunodeficiency syndrome	0.00026	0.00155	CcSEcCtD
Perphenazine—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.000259	0.00155	CcSEcCtD
Perphenazine—Loss of consciousness—Indinavir—acquired immunodeficiency syndrome	0.000259	0.00154	CcSEcCtD
Perphenazine—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.000258	0.00154	CcSEcCtD
Perphenazine—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.000258	0.00154	CcSEcCtD
Perphenazine—Hypoaesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000258	0.00154	CcSEcCtD
Perphenazine—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000257	0.00355	CbGeAlD
Perphenazine—HRH1—lung—acquired immunodeficiency syndrome	0.000257	0.00355	CbGeAlD
Perphenazine—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000257	0.00153	CcSEcCtD
Perphenazine—Cough—Indinavir—acquired immunodeficiency syndrome	0.000257	0.00153	CcSEcCtD
Perphenazine—Muscle spasms—Delavirdine—acquired immunodeficiency syndrome	0.000256	0.00153	CcSEcCtD
Perphenazine—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.000255	0.00152	CcSEcCtD
Perphenazine—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.000255	0.00152	CcSEcCtD
Perphenazine—HTR1A—brain—acquired immunodeficiency syndrome	0.000255	0.00352	CbGeAlD
Perphenazine—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000254	0.00152	CcSEcCtD
Perphenazine—Pain—Stavudine—acquired immunodeficiency syndrome	0.000254	0.00152	CcSEcCtD
Perphenazine—Constipation—Stavudine—acquired immunodeficiency syndrome	0.000254	0.00152	CcSEcCtD
Perphenazine—Shock—Zidovudine—acquired immunodeficiency syndrome	0.000254	0.00152	CcSEcCtD
Perphenazine—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.000254	0.00152	CcSEcCtD
Perphenazine—ADRA2A—lung—acquired immunodeficiency syndrome	0.000252	0.00348	CbGeAlD
Perphenazine—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000252	0.0015	CcSEcCtD
Perphenazine—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.000251	0.0015	CcSEcCtD
Perphenazine—CALM2—brain—acquired immunodeficiency syndrome	0.00025	0.00346	CbGeAlD
Perphenazine—Pain—Abacavir—acquired immunodeficiency syndrome	0.00025	0.00149	CcSEcCtD
Perphenazine—Syncope—Efavirenz—acquired immunodeficiency syndrome	0.000249	0.00149	CcSEcCtD
Perphenazine—CALM1—brain—acquired immunodeficiency syndrome	0.000249	0.00344	CbGeAlD
Perphenazine—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000246	0.00147	CcSEcCtD
Perphenazine—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.000245	0.00146	CcSEcCtD
Perphenazine—HTR2A—blood—acquired immunodeficiency syndrome	0.000245	0.00338	CbGeAlD
Perphenazine—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.000244	0.00146	CcSEcCtD
Perphenazine—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000244	0.00146	CcSEcCtD
Perphenazine—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.000244	0.00146	CcSEcCtD
Perphenazine—CYP2B6—nervous system—acquired immunodeficiency syndrome	0.000243	0.00336	CbGeAlD
Perphenazine—HTR7—brain—acquired immunodeficiency syndrome	0.000243	0.00336	CbGeAlD
Perphenazine—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000243	0.00145	CcSEcCtD
Perphenazine—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.000243	0.00145	CcSEcCtD
Perphenazine—Cough—Efavirenz—acquired immunodeficiency syndrome	0.000243	0.00145	CcSEcCtD
Perphenazine—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000242	0.00145	CcSEcCtD
Perphenazine—CALM2—lymph node—acquired immunodeficiency syndrome	0.000242	0.00334	CbGeAlD
Perphenazine—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000241	0.00144	CcSEcCtD
Perphenazine—CALM1—lymph node—acquired immunodeficiency syndrome	0.000241	0.00332	CbGeAlD
Perphenazine—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00024	0.00143	CcSEcCtD
Perphenazine—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.00024	0.00143	CcSEcCtD
Perphenazine—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.000239	0.00142	CcSEcCtD
Perphenazine—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000238	0.00142	CcSEcCtD
Perphenazine—HRH1—nervous system—acquired immunodeficiency syndrome	0.000238	0.00328	CbGeAlD
Perphenazine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000238	0.00328	CbGeAlD
Perphenazine—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.000237	0.00141	CcSEcCtD
Perphenazine—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000237	0.00141	CcSEcCtD
Perphenazine—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.000236	0.00141	CcSEcCtD
Perphenazine—Shock—Indinavir—acquired immunodeficiency syndrome	0.000236	0.00141	CcSEcCtD
Perphenazine—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000236	0.00141	CcSEcCtD
Perphenazine—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000236	0.00325	CbGeAlD
Perphenazine—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000236	0.00141	CcSEcCtD
Perphenazine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000235	0.0014	CcSEcCtD
Perphenazine—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000235	0.0014	CcSEcCtD
Perphenazine—CYP2B6—central nervous system—acquired immunodeficiency syndrome	0.000234	0.00324	CbGeAlD
Perphenazine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000234	0.0014	CcSEcCtD
Perphenazine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000234	0.00323	CbGeAlD
Perphenazine—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.000234	0.0014	CcSEcCtD
Perphenazine—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000234	0.00322	CbGeAlD
Perphenazine—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000234	0.00139	CcSEcCtD
Perphenazine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000232	0.00139	CcSEcCtD
Perphenazine—Cough—Delavirdine—acquired immunodeficiency syndrome	0.000232	0.00139	CcSEcCtD
Perphenazine—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.000232	0.00138	CcSEcCtD
Perphenazine—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000231	0.00138	CcSEcCtD
Perphenazine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000231	0.00138	CcSEcCtD
Perphenazine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.00023	0.00137	CcSEcCtD
Perphenazine—DRD2—brain—acquired immunodeficiency syndrome	0.00023	0.00318	CbGeAlD
Perphenazine—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.00023	0.00137	CcSEcCtD
Perphenazine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00023	0.00137	CcSEcCtD
Perphenazine—HRH1—central nervous system—acquired immunodeficiency syndrome	0.000229	0.00316	CbGeAlD
Perphenazine—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000229	0.00137	CcSEcCtD
Perphenazine—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000229	0.00137	CcSEcCtD
Perphenazine—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.000228	0.00136	CcSEcCtD
Perphenazine—HTR2A—vagina—acquired immunodeficiency syndrome	0.000227	0.00313	CbGeAlD
Perphenazine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000227	0.00135	CcSEcCtD
Perphenazine—CYP3A4—blood—acquired immunodeficiency syndrome	0.000226	0.00313	CbGeAlD
Perphenazine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000226	0.00135	CcSEcCtD
Perphenazine—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000226	0.00135	CcSEcCtD
Perphenazine—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.000225	0.0031	CbGeAlD
Perphenazine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000224	0.00134	CcSEcCtD
Perphenazine—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000223	0.00133	CcSEcCtD
Perphenazine—CYP2D6—blood—acquired immunodeficiency syndrome	0.000223	0.00308	CbGeAlD
Perphenazine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000221	0.00132	CcSEcCtD
Perphenazine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000221	0.00132	CcSEcCtD
Perphenazine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000221	0.00132	CcSEcCtD
Perphenazine—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000221	0.00132	CcSEcCtD
Perphenazine—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000221	0.00132	CcSEcCtD
Perphenazine—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.00022	0.00131	CcSEcCtD
Perphenazine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00022	0.00131	CcSEcCtD
Perphenazine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000219	0.00131	CcSEcCtD
Perphenazine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000219	0.00131	CcSEcCtD
Perphenazine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000218	0.0013	CcSEcCtD
Perphenazine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000218	0.0013	CcSEcCtD
Perphenazine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000217	0.0013	CcSEcCtD
Perphenazine—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000217	0.0013	CcSEcCtD
Perphenazine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000216	0.00129	CcSEcCtD
Perphenazine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000216	0.00129	CcSEcCtD
Perphenazine—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000216	0.00129	CcSEcCtD
Perphenazine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000216	0.00129	CcSEcCtD
Perphenazine—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000215	0.00128	CcSEcCtD
Perphenazine—HTR2A—lung—acquired immunodeficiency syndrome	0.000214	0.00296	CbGeAlD
Perphenazine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000214	0.00128	CcSEcCtD
Perphenazine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000214	0.00128	CcSEcCtD
Perphenazine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000214	0.00127	CcSEcCtD
Perphenazine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000213	0.00127	CcSEcCtD
Perphenazine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000213	0.00127	CcSEcCtD
Perphenazine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000212	0.00127	CcSEcCtD
Perphenazine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000212	0.00127	CcSEcCtD
Perphenazine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000212	0.00126	CcSEcCtD
Perphenazine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000212	0.00126	CcSEcCtD
Perphenazine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000211	0.00126	CcSEcCtD
Perphenazine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00021	0.00126	CcSEcCtD
Perphenazine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00021	0.00125	CcSEcCtD
Perphenazine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000209	0.00125	CcSEcCtD
Perphenazine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000208	0.00124	CcSEcCtD
Perphenazine—CYP2C8—brain—acquired immunodeficiency syndrome	0.000207	0.00286	CbGeAlD
Perphenazine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000207	0.00124	CcSEcCtD
Perphenazine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000207	0.00124	CcSEcCtD
Perphenazine—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000207	0.00123	CcSEcCtD
Perphenazine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000206	0.00123	CcSEcCtD
Perphenazine—Pain—Indinavir—acquired immunodeficiency syndrome	0.000205	0.00123	CcSEcCtD
Perphenazine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000205	0.00123	CcSEcCtD
Perphenazine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000205	0.00122	CcSEcCtD
Perphenazine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000205	0.00122	CcSEcCtD
Perphenazine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000205	0.00122	CcSEcCtD
Perphenazine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000205	0.00122	CcSEcCtD
Perphenazine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000204	0.00122	CcSEcCtD
Perphenazine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000204	0.00122	CcSEcCtD
Perphenazine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000204	0.00122	CcSEcCtD
Perphenazine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000203	0.00121	CcSEcCtD
Perphenazine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000203	0.00121	CcSEcCtD
Perphenazine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000203	0.00121	CcSEcCtD
Perphenazine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000202	0.00121	CcSEcCtD
Perphenazine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000202	0.00121	CcSEcCtD
Perphenazine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000202	0.00121	CcSEcCtD
Perphenazine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000202	0.0012	CcSEcCtD
Perphenazine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.0002	0.0012	CcSEcCtD
Perphenazine—HTR2A—nervous system—acquired immunodeficiency syndrome	0.000199	0.00274	CbGeAlD
Perphenazine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000198	0.00118	CcSEcCtD
Perphenazine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000197	0.00118	CcSEcCtD
Perphenazine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000197	0.00118	CcSEcCtD
Perphenazine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000197	0.00118	CcSEcCtD
Perphenazine—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000197	0.00118	CcSEcCtD
Perphenazine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000197	0.00118	CcSEcCtD
Perphenazine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000196	0.00117	CcSEcCtD
Perphenazine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000196	0.00117	CcSEcCtD
Perphenazine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000196	0.00117	CcSEcCtD
Perphenazine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000196	0.00117	CcSEcCtD
Perphenazine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000195	0.00116	CcSEcCtD
Perphenazine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000194	0.00116	CcSEcCtD
Perphenazine—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000194	0.00116	CcSEcCtD
Perphenazine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000194	0.00116	CcSEcCtD
Perphenazine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000194	0.00116	CcSEcCtD
Perphenazine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000193	0.00115	CcSEcCtD
Perphenazine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000193	0.00115	CcSEcCtD
Perphenazine—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000192	0.00115	CcSEcCtD
Perphenazine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000191	0.00114	CcSEcCtD
Perphenazine—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000191	0.00264	CbGeAlD
Perphenazine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000191	0.00114	CcSEcCtD
Perphenazine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.00113	CcSEcCtD
Perphenazine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00019	0.00113	CcSEcCtD
Perphenazine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000189	0.00113	CcSEcCtD
Perphenazine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000188	0.00112	CcSEcCtD
Perphenazine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000188	0.00112	CcSEcCtD
Perphenazine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000187	0.00111	CcSEcCtD
Perphenazine—CYP2B6—brain—acquired immunodeficiency syndrome	0.000186	0.00257	CbGeAlD
Perphenazine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000186	0.00111	CcSEcCtD
Perphenazine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000186	0.00111	CcSEcCtD
Perphenazine—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000186	0.00111	CcSEcCtD
Perphenazine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000186	0.00111	CcSEcCtD
Perphenazine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.0011	CcSEcCtD
Perphenazine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000184	0.0011	CcSEcCtD
Perphenazine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000184	0.00254	CbGeAlD
Perphenazine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000183	0.00109	CcSEcCtD
Perphenazine—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000183	0.00109	CcSEcCtD
Perphenazine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000183	0.00109	CcSEcCtD
Perphenazine—HRH1—brain—acquired immunodeficiency syndrome	0.000182	0.00251	CbGeAlD
Perphenazine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000182	0.00108	CcSEcCtD
Perphenazine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.00108	CcSEcCtD
Perphenazine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000181	0.0025	CbGeAlD
Perphenazine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000181	0.00108	CcSEcCtD
Perphenazine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00018	0.00108	CcSEcCtD
Perphenazine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000179	0.00107	CcSEcCtD
Perphenazine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.00107	CcSEcCtD
Perphenazine—ADRA2A—brain—acquired immunodeficiency syndrome	0.000179	0.00247	CbGeAlD
Perphenazine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.00107	CcSEcCtD
Perphenazine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000177	0.00244	CbGeAlD
Perphenazine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000177	0.00106	CcSEcCtD
Perphenazine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000177	0.00105	CcSEcCtD
Perphenazine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.00105	CcSEcCtD
Perphenazine—HRH1—lymph node—acquired immunodeficiency syndrome	0.000176	0.00242	CbGeAlD
Perphenazine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.00104	CcSEcCtD
Perphenazine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000174	0.00104	CcSEcCtD
Perphenazine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000174	0.00241	CbGeAlD
Perphenazine—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.000173	0.00238	CbGeAlD
Perphenazine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000172	0.00103	CcSEcCtD
Perphenazine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.00103	CcSEcCtD
Perphenazine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.00103	CcSEcCtD
Perphenazine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.00103	CcSEcCtD
Perphenazine—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000172	0.00102	CcSEcCtD
Perphenazine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000172	0.00102	CcSEcCtD
Perphenazine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000172	0.00102	CcSEcCtD
Perphenazine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000171	0.00102	CcSEcCtD
Perphenazine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00017	0.00101	CcSEcCtD
Perphenazine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000168	0.001	CcSEcCtD
Perphenazine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000167	0.000998	CcSEcCtD
Perphenazine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.000995	CcSEcCtD
Perphenazine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000165	0.000986	CcSEcCtD
Perphenazine—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000165	0.000986	CcSEcCtD
Perphenazine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.000981	CcSEcCtD
Perphenazine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000164	0.000981	CcSEcCtD
Perphenazine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.000978	CcSEcCtD
Perphenazine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000162	0.000966	CcSEcCtD
Perphenazine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00016	0.000958	CcSEcCtD
Perphenazine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.000956	CcSEcCtD
Perphenazine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00016	0.000955	CcSEcCtD
Perphenazine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.000952	CcSEcCtD
Perphenazine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000159	0.000948	CcSEcCtD
Perphenazine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.000947	CcSEcCtD
Perphenazine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000158	0.000941	CcSEcCtD
Perphenazine—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000158	0.000941	CcSEcCtD
Perphenazine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000155	0.000927	CcSEcCtD
Perphenazine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.000917	CcSEcCtD
Perphenazine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.000916	CcSEcCtD
Perphenazine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.000912	CcSEcCtD
Perphenazine—HTR2A—brain—acquired immunodeficiency syndrome	0.000152	0.0021	CbGeAlD
Perphenazine—Headache—Indinavir—acquired immunodeficiency syndrome	0.00015	0.000898	CcSEcCtD
Perphenazine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00015	0.000896	CcSEcCtD
Perphenazine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000149	0.000887	CcSEcCtD
Perphenazine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.000883	CcSEcCtD
Perphenazine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.000874	CcSEcCtD
Perphenazine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.00087	CcSEcCtD
Perphenazine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.000857	CcSEcCtD
Perphenazine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.00085	CcSEcCtD
Perphenazine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000142	0.000848	CcSEcCtD
Perphenazine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000848	CcSEcCtD
Perphenazine—CYP2D6—brain—acquired immunodeficiency syndrome	0.000138	0.00191	CbGeAlD
Perphenazine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000137	0.00082	CcSEcCtD
Perphenazine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000816	CcSEcCtD
Perphenazine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000136	0.000812	CcSEcCtD
Perphenazine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000811	CcSEcCtD
Perphenazine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000792	CcSEcCtD
Perphenazine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000132	0.000789	CcSEcCtD
Perphenazine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000778	CcSEcCtD
Perphenazine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000763	CcSEcCtD
Perphenazine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.000753	CcSEcCtD
Perphenazine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.000751	CcSEcCtD
Perphenazine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000728	CcSEcCtD
Perphenazine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000723	CcSEcCtD
Perphenazine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000689	CcSEcCtD
Perphenazine—Acepromazine—ALB—acquired immunodeficiency syndrome	7.9e-05	0.193	CrCbGaD
Perphenazine—Thioproperazine—ALB—acquired immunodeficiency syndrome	7.72e-05	0.189	CrCbGaD
Perphenazine—Thiothixene—ALB—acquired immunodeficiency syndrome	7.6e-05	0.186	CrCbGaD
Perphenazine—Pipotiazine—ALB—acquired immunodeficiency syndrome	7.6e-05	0.186	CrCbGaD
Perphenazine—Clomipramine—ALB—acquired immunodeficiency syndrome	6.01e-05	0.147	CrCbGaD
Perphenazine—Chlorpromazine—ALB—acquired immunodeficiency syndrome	4.12e-05	0.101	CrCbGaD
Perphenazine—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.56e-05	0.000394	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.56e-05	0.000394	CbGpPWpGaD
Perphenazine—CALM3—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	1.56e-05	0.000394	CbGpPWpGaD
Perphenazine—CALM3—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	1.56e-05	0.000392	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.55e-05	0.000392	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.55e-05	0.000391	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.55e-05	0.000391	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.55e-05	0.00039	CbGpPWpGaD
Perphenazine—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.54e-05	0.000388	CbGpPWpGaD
Perphenazine—CALM2—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	1.54e-05	0.000388	CbGpPWpGaD
Perphenazine—CALM2—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	1.54e-05	0.000388	CbGpPWpGaD
Perphenazine—CALM2—DAP12 interactions—IL6—acquired immunodeficiency syndrome	1.54e-05	0.000388	CbGpPWpGaD
Perphenazine—CALM1—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	1.54e-05	0.000388	CbGpPWpGaD
Perphenazine—CALM1—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	1.54e-05	0.000388	CbGpPWpGaD
Perphenazine—CALM1—DAP12 interactions—IL6—acquired immunodeficiency syndrome	1.54e-05	0.000388	CbGpPWpGaD
Perphenazine—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.54e-05	0.000387	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.53e-05	0.000386	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.53e-05	0.000385	CbGpPWpGaD
Perphenazine—CALM2—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	1.52e-05	0.000384	CbGpPWpGaD
Perphenazine—CALM1—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	1.52e-05	0.000384	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.52e-05	0.000384	CbGpPWpGaD
Perphenazine—CALM2—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	1.51e-05	0.000381	CbGpPWpGaD
Perphenazine—CALM1—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	1.51e-05	0.000381	CbGpPWpGaD
Perphenazine—CALM2—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	1.5e-05	0.000379	CbGpPWpGaD
Perphenazine—CALM1—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	1.5e-05	0.000379	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.48e-05	0.000374	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IFNA1—acquired immunodeficiency syndrome	1.48e-05	0.000373	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.48e-05	0.000372	CbGpPWpGaD
Perphenazine—CALM3—Hemostasis—ALB—acquired immunodeficiency syndrome	1.44e-05	0.000363	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.44e-05	0.000363	CbGpPWpGaD
Perphenazine—CALM3—Immune System—CD79A—acquired immunodeficiency syndrome	1.44e-05	0.000362	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.43e-05	0.000361	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IFNA1—acquired immunodeficiency syndrome	1.43e-05	0.000361	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IFNA1—acquired immunodeficiency syndrome	1.43e-05	0.000361	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.43e-05	0.000361	CbGpPWpGaD
Perphenazine—CALM3—Disease—CXCR4—acquired immunodeficiency syndrome	1.43e-05	0.00036	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.42e-05	0.000358	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.42e-05	0.000357	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.41e-05	0.000356	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.41e-05	0.000356	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.41e-05	0.000356	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.41e-05	0.000355	CbGpPWpGaD
Perphenazine—CALM3—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	1.41e-05	0.000355	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.4e-05	0.000353	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.4e-05	0.000352	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.39e-05	0.000351	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.39e-05	0.000351	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.39e-05	0.000351	CbGpPWpGaD
Perphenazine—CALM1—Hemostasis—ALB—acquired immunodeficiency syndrome	1.39e-05	0.000351	CbGpPWpGaD
Perphenazine—CALM2—Hemostasis—ALB—acquired immunodeficiency syndrome	1.39e-05	0.000351	CbGpPWpGaD
Perphenazine—CALM1—Immune System—CD79A—acquired immunodeficiency syndrome	1.39e-05	0.00035	CbGpPWpGaD
Perphenazine—CALM2—Immune System—CD79A—acquired immunodeficiency syndrome	1.39e-05	0.00035	CbGpPWpGaD
Perphenazine—HTR6—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.39e-05	0.00035	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.39e-05	0.00035	CbGpPWpGaD
Perphenazine—HTR7—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.39e-05	0.00035	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.39e-05	0.00035	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.39e-05	0.00035	CbGpPWpGaD
Perphenazine—CALM2—Disease—CXCR4—acquired immunodeficiency syndrome	1.38e-05	0.000348	CbGpPWpGaD
Perphenazine—CALM1—Disease—CXCR4—acquired immunodeficiency syndrome	1.38e-05	0.000348	CbGpPWpGaD
Perphenazine—CALM1—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	1.36e-05	0.000343	CbGpPWpGaD
Perphenazine—CALM2—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	1.36e-05	0.000343	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.33e-05	0.000335	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.3e-05	0.000328	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.29e-05	0.000325	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.29e-05	0.000325	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.29e-05	0.000325	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.29e-05	0.000324	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.28e-05	0.000323	CbGpPWpGaD
Perphenazine—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	1.28e-05	0.000323	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.28e-05	0.000322	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.27e-05	0.00032	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.27e-05	0.00032	CbGpPWpGaD
Perphenazine—HTR6—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.26e-05	0.000318	CbGpPWpGaD
Perphenazine—HTR7—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.26e-05	0.000318	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.25e-05	0.000314	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.25e-05	0.000314	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.23e-05	0.000311	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.23e-05	0.000309	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.23e-05	0.000309	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.22e-05	0.000308	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.22e-05	0.000308	CbGpPWpGaD
Perphenazine—CYP2C18—Metabolism—ALB—acquired immunodeficiency syndrome	1.22e-05	0.000308	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.21e-05	0.000306	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.2e-05	0.000304	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.2e-05	0.000304	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.2e-05	0.000303	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.2e-05	0.000303	CbGpPWpGaD
Perphenazine—DRD1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.2e-05	0.000302	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.18e-05	0.000296	CbGpPWpGaD
Perphenazine—CALM3—Immune System—CD40LG—acquired immunodeficiency syndrome	1.17e-05	0.000295	CbGpPWpGaD
Perphenazine—CALM3—Hemostasis—IL2—acquired immunodeficiency syndrome	1.17e-05	0.000294	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.17e-05	0.000294	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.16e-05	0.000292	CbGpPWpGaD
Perphenazine—CALM3—Immune System—CD8A—acquired immunodeficiency syndrome	1.16e-05	0.000292	CbGpPWpGaD
Perphenazine—CALM3—Immune System—CSF2—acquired immunodeficiency syndrome	1.16e-05	0.000292	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—CD4—acquired immunodeficiency syndrome	1.14e-05	0.000288	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.14e-05	0.000287	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.14e-05	0.000287	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.14e-05	0.000287	CbGpPWpGaD
Perphenazine—CALM1—Immune System—CD40LG—acquired immunodeficiency syndrome	1.13e-05	0.000286	CbGpPWpGaD
Perphenazine—CALM2—Immune System—CD40LG—acquired immunodeficiency syndrome	1.13e-05	0.000286	CbGpPWpGaD
Perphenazine—CALM1—Hemostasis—IL2—acquired immunodeficiency syndrome	1.13e-05	0.000285	CbGpPWpGaD
Perphenazine—CALM2—Hemostasis—IL2—acquired immunodeficiency syndrome	1.13e-05	0.000285	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.12e-05	0.000283	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.12e-05	0.000283	CbGpPWpGaD
Perphenazine—CALM1—Immune System—CSF2—acquired immunodeficiency syndrome	1.12e-05	0.000282	CbGpPWpGaD
Perphenazine—CALM2—Immune System—CD8A—acquired immunodeficiency syndrome	1.12e-05	0.000282	CbGpPWpGaD
Perphenazine—CALM2—Immune System—CSF2—acquired immunodeficiency syndrome	1.12e-05	0.000282	CbGpPWpGaD
Perphenazine—CALM1—Immune System—CD8A—acquired immunodeficiency syndrome	1.12e-05	0.000282	CbGpPWpGaD
Perphenazine—CALM3—Immune System—HLA-B—acquired immunodeficiency syndrome	1.11e-05	0.000281	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.11e-05	0.00028	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—CD4—acquired immunodeficiency syndrome	1.11e-05	0.000279	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—CD4—acquired immunodeficiency syndrome	1.11e-05	0.000279	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	1.1e-05	0.000277	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.1e-05	0.000276	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.1e-05	0.000276	CbGpPWpGaD
Perphenazine—DRD1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.09e-05	0.000274	CbGpPWpGaD
Perphenazine—CALM3—Signaling by NGF—IL6—acquired immunodeficiency syndrome	1.08e-05	0.000273	CbGpPWpGaD
Perphenazine—CALM2—Immune System—HLA-B—acquired immunodeficiency syndrome	1.08e-05	0.000272	CbGpPWpGaD
Perphenazine—CALM1—Immune System—HLA-B—acquired immunodeficiency syndrome	1.08e-05	0.000272	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.06e-05	0.000268	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	1.06e-05	0.000267	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	1.06e-05	0.000267	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.06e-05	0.000267	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.06e-05	0.000266	CbGpPWpGaD
Perphenazine—CALM2—Signaling by NGF—IL6—acquired immunodeficiency syndrome	1.05e-05	0.000264	CbGpPWpGaD
Perphenazine—CALM1—Signaling by NGF—IL6—acquired immunodeficiency syndrome	1.05e-05	0.000264	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.04e-05	0.000263	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.04e-05	0.000262	CbGpPWpGaD
Perphenazine—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.03e-05	0.000259	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.03e-05	0.000259	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.03e-05	0.000259	CbGpPWpGaD
Perphenazine—AOX1—Disease—IL6—acquired immunodeficiency syndrome	1.03e-05	0.000259	CbGpPWpGaD
Perphenazine—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.02e-05	0.000258	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.02e-05	0.000257	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1e-05	0.000252	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1e-05	0.000252	CbGpPWpGaD
Perphenazine—CALM3—Disease—CCR5—acquired immunodeficiency syndrome	9.78e-06	0.000247	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.67e-06	0.000244	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.67e-06	0.000244	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.67e-06	0.000244	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.67e-06	0.000244	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.55e-06	0.000241	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.51e-06	0.00024	CbGpPWpGaD
Perphenazine—CALM2—Disease—CCR5—acquired immunodeficiency syndrome	9.47e-06	0.000239	CbGpPWpGaD
Perphenazine—CALM1—Disease—CCR5—acquired immunodeficiency syndrome	9.47e-06	0.000239	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.35e-06	0.000236	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.31e-06	0.000235	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.3e-06	0.000234	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9.28e-06	0.000234	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.17e-06	0.000231	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.16e-06	0.000231	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.14e-06	0.00023	CbGpPWpGaD
Perphenazine—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.04e-06	0.000228	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.03e-06	0.000227	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.01e-06	0.000227	CbGpPWpGaD
Perphenazine—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.89e-06	0.000224	CbGpPWpGaD
Perphenazine—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.87e-06	0.000224	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.39e-06	0.000211	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.34e-06	0.00021	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.25e-06	0.000208	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.24e-06	0.000208	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.21e-06	0.000207	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.21e-06	0.000207	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.09e-06	0.000204	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.07e-06	0.000203	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.06e-06	0.000203	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	7.93e-06	0.0002	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.61e-06	0.000192	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.51e-06	0.000189	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.49e-06	0.000189	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.46e-06	0.000188	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.45e-06	0.000188	CbGpPWpGaD
Perphenazine—HTR6—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.42e-06	0.000187	CbGpPWpGaD
Perphenazine—HTR7—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.41e-06	0.000187	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.36e-06	0.000185	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.36e-06	0.000185	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.35e-06	0.000185	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.25e-06	0.000183	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.25e-06	0.000183	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IFNG—acquired immunodeficiency syndrome	6.89e-06	0.000174	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.85e-06	0.000173	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.7e-06	0.000169	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IFNG—acquired immunodeficiency syndrome	6.67e-06	0.000168	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IFNG—acquired immunodeficiency syndrome	6.67e-06	0.000168	CbGpPWpGaD
Perphenazine—CALM3—Immune System—CD4—acquired immunodeficiency syndrome	6.66e-06	0.000168	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.63e-06	0.000167	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.63e-06	0.000167	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.48e-06	0.000163	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.48e-06	0.000163	CbGpPWpGaD
Perphenazine—CALM2—Immune System—CD4—acquired immunodeficiency syndrome	6.44e-06	0.000162	CbGpPWpGaD
Perphenazine—CALM1—Immune System—CD4—acquired immunodeficiency syndrome	6.44e-06	0.000162	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.42e-06	0.000162	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	6.4e-06	0.000161	CbGpPWpGaD
Perphenazine—DRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.39e-06	0.000161	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—IL6—acquired immunodeficiency syndrome	6.18e-06	0.000156	CbGpPWpGaD
Perphenazine—CALM3—Disease—CD4—acquired immunodeficiency syndrome	6.14e-06	0.000155	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IL2—acquired immunodeficiency syndrome	6.12e-06	0.000154	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—ALB—acquired immunodeficiency syndrome	6e-06	0.000151	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—IL6—acquired immunodeficiency syndrome	5.98e-06	0.000151	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—IL6—acquired immunodeficiency syndrome	5.98e-06	0.000151	CbGpPWpGaD
Perphenazine—CALM2—Disease—CD4—acquired immunodeficiency syndrome	5.94e-06	0.00015	CbGpPWpGaD
Perphenazine—CALM1—Disease—CD4—acquired immunodeficiency syndrome	5.94e-06	0.00015	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IL2—acquired immunodeficiency syndrome	5.92e-06	0.000149	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IL2—acquired immunodeficiency syndrome	5.92e-06	0.000149	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—ALB—acquired immunodeficiency syndrome	5.84e-06	0.000147	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—ALB—acquired immunodeficiency syndrome	5.65e-06	0.000142	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—ALB—acquired immunodeficiency syndrome	5.65e-06	0.000142	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.52e-06	0.000139	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.49e-06	0.000138	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.49e-06	0.000138	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.46e-06	0.000138	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—ALB—acquired immunodeficiency syndrome	5.08e-06	0.000128	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.85e-06	0.000122	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.82e-06	0.000122	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.77e-06	0.00012	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.76e-06	0.00012	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.75e-06	0.00012	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.74e-06	0.000119	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	4.53e-06	0.000114	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.38e-06	0.00011	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.38e-06	0.00011	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.34e-06	0.000109	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.32e-06	0.000109	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	4.17e-06	0.000105	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	4.13e-06	0.000104	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.96e-06	9.98e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.94e-06	9.93e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.83e-06	9.65e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.83e-06	9.65e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.81e-06	9.6e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.81e-06	9.6e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.77e-06	9.51e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IL6—acquired immunodeficiency syndrome	3.6e-06	9.07e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	3.53e-06	8.9e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IL6—acquired immunodeficiency syndrome	3.48e-06	8.77e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IL6—acquired immunodeficiency syndrome	3.48e-06	8.77e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—IL6—acquired immunodeficiency syndrome	3.32e-06	8.37e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.24e-06	8.18e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.23e-06	8.14e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—IL6—acquired immunodeficiency syndrome	3.21e-06	8.1e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—IL6—acquired immunodeficiency syndrome	3.21e-06	8.1e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.85e-06	7.18e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.8e-06	7.06e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.8e-06	7.05e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	2.73e-06	6.87e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.55e-06	6.43e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.33e-06	5.86e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.25e-06	5.67e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.25e-06	5.67e-05	CbGpPWpGaD
